The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liang, Z.
Right arrow Articles by Mohan, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liang, Z.
Right arrow Articles by Mohan, C.
The Journal of Immunology, 2003, 171: 3886-3894.
Copyright © 2003 by The American Association of Immunologists

Molecular Signatures of Anti-nuclear Antibodies: Contributions of Specific Light Chain Residues and a Novel New Zealand Black V{kappa}1 Germline Gene 1

Zhiyan Liang, Cui Chen and Chandra Mohan2

Simmons Arthritis Research Center and Center for Immunology, University of Texas Southwestern Medical School, Dallas, TX 75235

Although the Ig H chains of anti-nuclear Abs (ANA) have been described to possess certain shared molecular signatures, it remains unclear whether the L chains of these Abs also possess distinctive molecular features. The present study examines this by generating and analyzing two comprehensive murine Ig L chain databases, one consisting of 264 monoclonal ANAs and the other consisting of 145 non-ANAs, drawn from previously published work. Importantly, clonal replicates were represented only once each, so as to minimize bias. ANAs and non-ANAs did not differ in V{kappa} family or J{kappa} gene usage, nor in their mutation frequencies. Interestingly, the L chains of ANAs exhibited differential usage of certain complementarity-determining region residues, arising almost entirely from the increased usage of certain V{kappa} germline genes, notably, V{kappa} ai4 among anti-dsDNA ANAs, V{kappa}23–45 among anti-ssDNA ANAs, and V{kappa}21–12 among non-ANAs. Finally, prompted by the increased prevalence of a particular V{kappa}1 family sequence among ANAs, we proceeded to clone a novel New Zealand Black V{kappa}1 germline gene, named bb1.1, which appears to be frequently used to encoded anti-ssDNA Abs. Collectively, these studies underline the potential contribution of particular V{kappa} germline genes in promoting or thwarting DNA binding.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Chen, H. Li, Q. Tian, M. Beardall, Y. Xu, N. Casanova, and M. Weigert
Selection of Anti-Double-Stranded DNA B Cells in Autoimmune MRL-lpr/lpr Mice
J. Immunol., May 1, 2006; 176(9): 5183 - 5190.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Z. Liang, C. Xie, C. Chen, D. Kreska, K. Hsu, L. Li, X. J. Zhou, and C. Mohan
Pathogenic Profiles and Molecular Signatures of Antinuclear Autoantibodies Rescued from NZM2410 Lupus Mice
J. Exp. Med., February 2, 2004; 199(3): 381 - 398.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.